Aw. Dekker et al., INFECTION PREVENTION IN AUTOLOGOUS BONE-MARROW TRANSPLANTATION AND THE ROLE OF PROTECTIVE ISOLATION, Bone marrow transplantation, 14(1), 1994, pp. 89-93
The efficacy of an antimicrobial regimen for prevention of infections
was prospectively evaluated in 113 patients undergoing autologous bone
marrow transplantation (BMT). Ciprofloxacin, 500 mg orally twice a da
y plus antifungal prophylaxis, fluconazole 50 mg once daily plus ampho
tericin B tablets or suspension and tablets, each 200 mg four times a
day, was given. In addition all patients received streptococcal prophy
laxis for 10 days after BMT. Documented infections occurred in 39% (44
of 113) of patients and unexplained fever in 27% (30 of 113). The eff
icacy of this regimen was reflected in a low mortality rate (3.5%) fro
m infections and in the low need for intravenous amphotericin B (7%).
No benefit of protective isolation was found in 59 patients compared w
ith 54 patients treated without isolation measures.